Literature DB >> 11574277

HLA-G remains a mystery.

D Bainbridge1, S Ellis, P Le Bouteiller, I Sargent.   

Abstract

In this brief summary, we argue that many widely held beliefs about HLA-G are questionable. Recent research has led to a re-evaluation of many of the characteristics that were thought to make HLA-G unusual among the MHC class I molecules. First, contrary to reports suggesting that the gene encoding HLA-G exhibits marked polymorphism in some human populations, recent data have shown that the HLA-G gene has comparatively little polymorphism - a feature that might allow it to be expressed in the placenta without causing rejection by the maternal immune system. Second, although truncated forms of HLA-G are generated in the placenta, most of them are unlikely to have significant biological effects as they do not reach the cell surface. Third, the hypothesis that a major role of HLA-G is to prevent attack of the placenta by maternal natural killer cells is now the subject of renewed scrutiny. Finally, there is little evidence that the induction of expression of HLA-G is a major mechanism by which tumor cells avoid immune attack. HLA-G has once again become as mysterious as when it was discovered: an MHC class I molecule expressed at a challengingly extraordinary site--the immunologically uneasy interface between mother and fetus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574277     DOI: 10.1016/s1471-4906(01)02031-2

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  19 in total

1.  A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells.

Authors:  Michael J Paidas; Graciela Krikun; S Joseph Huang; Richard Jones; Michael Romano; Jack Annunziato; Eytan R Barnea
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

3.  Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.

Authors:  Craig S Clements; Lars Kjer-Nielsen; Lyudmila Kostenko; Hilary L Hoare; Michelle A Dunstone; Eric Moses; Katy Freed; Andrew G Brooks; Jamie Rossjohn; James McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-17       Impact factor: 11.205

Review 4.  HLA class I expression in the human placenta.

Authors:  Herbert Juch; Astrid Blaschitz; Gottfried Dohr; Heinz Hutter
Journal:  Wien Med Wochenschr       Date:  2012-05

5.  Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites.

Authors:  Pierre Lau; Claire Amadou; Hélène Brun; Virginie Rouillon; Fiona McLaren; Anne-France Le Rolle; Margaret Graham; Geoffrey W Butcher; Etienne Joly
Journal:  BMC Immunol       Date:  2003-07-01       Impact factor: 3.615

6.  A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Authors:  Bruce A C Cree; John D Rioux; Jacob L McCauley; Pierre-Antoine F D Gourraud; Philippe Goyette; Joseph McElroy; Philip De Jager; Adam Santaniello; Timothy J Vyse; Peter K Gregersen; Daniel Mirel; David A Hafler; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen J Sawcer; Jorge R Oksenberg; Stephen L Hauser
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

Review 7.  Complement activation and pregnancy failure.

Authors:  Angela Tincani; Ilaria Cavazzana; Tamara Ziglioli; Andrea Lojacono; Valentina De Angelis; Pierluigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

8.  HLA-G does not have a pathophysiological role in Graves' disease.

Authors:  E H Kemp; R A Metcalfe; P F Watson; A P Weetman
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 9.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

10.  The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt.

Authors:  Craig S Clements; Lars Kjer-Nielsen; Lyudmila Kostenko; James McCluskey; Jamie Rossjohn
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.